Real-time enrollment status for this ulcerative colitis clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05181137 |
| Recruiting Status | Unknown |
| Condition | Ulcerative Colitis |
| Phase | Clinical Trial |
| Target Enrollment | 368 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Reistone Biopharma Company Limited |
| Last Updated on CT.gov | September 5, 2023 (Sep 5, 2023) |
As of March 2, 2026: Clinical trial NCT05181137 is currently unknown participants. This clinical trial study for ulcerative colitis is not currently accepting new participants at 23 locations across the United States. The study is sponsored by Reistone Biopharma Company Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05181137 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05181137 was last updated Sep 5, 2023 (September 5, 2023). HelloStudys verifies this status automatically.